Yes. The opposite was actually used as the reason for doing clinical trials. The idea was that because you don't get access to the innovative medicines, you should be doing clinical trials in New Zealand, because then patients could actually.... The Health Select Committee investigated this. That was one of the pros for doing trials.
The two are not necessarily linked, to be quite frank. Our companies do a lot of clinical trials in New Zealand; I would like to see them do more. Perversely, I think it is one way of getting access to the innovative medicines. That's why New Zealand is a really good place to recruit for studies. In fact, studies are often moved from Australia to New Zealand because the patients need access. I'm sorry to say it as a New Zealander, but that is actually the case.